These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 38307574)
1. Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal Adenocarcinoma. Ke TW; Zwane ST; Chiang SF; Chen TW; Yang PC; Chen LC; Lin YS; Chen WT; Chao KSC; Huang KC Anticancer Res; 2024 Feb; 44(2):787-796. PubMed ID: 38307574 [TBL] [Abstract][Full Text] [Related]
2. Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma. Farchoukh L; Hartman DJ; Ma C; Celebrezze J; Medich D; Bahary N; Frank M; Pantanowitz L; Pai RK Mod Pathol; 2021 Jan; 34(1):171-183. PubMed ID: 32661298 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of immunoscore related markers in bladder cancer. Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861 [TBL] [Abstract][Full Text] [Related]
4. The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer: Implications for Immune Activation and Therapy Response. Chen CC; Wu ML; Huang KC; Huang IP; Chung YL Clin Colorectal Cancer; 2020 Dec; 19(4):e164-e180. PubMed ID: 32387305 [TBL] [Abstract][Full Text] [Related]
5. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma. Rauser S; Langer R; Tschernitz S; Gais P; Jütting U; Feith M; Höfler H; Walch A BMC Cancer; 2010 Nov; 10():608. PubMed ID: 21054833 [TBL] [Abstract][Full Text] [Related]
6. Potential role of tumor-infiltrating T-, B-lymphocytes, tumor-associated macrophages and IgA-secreting plasma cells in long-term survival in the rectal adenocarcinoma patients. Zinovkin DA; Kose SY; Nadyrov EA; Achinovich SL; Los' DM; Gavrilenko TE; Gavrilenko DI; Yuzugulen J; Pranjol MZI Life Sci; 2021 Dec; 286():120052. PubMed ID: 34656554 [TBL] [Abstract][Full Text] [Related]
7. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864 [TBL] [Abstract][Full Text] [Related]
8. The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma. Uppal A; Dehal A; Chang SC; Barrak D; Naeini Y; Jalas JR; Bilchik AJ J Gastrointest Surg; 2020 Jan; 24(1):28-38. PubMed ID: 31625020 [TBL] [Abstract][Full Text] [Related]
9. The local immune phenotype influences prognosis in patients with nodal-positive rectal cancer after neoadjuvant chemoradiation. Schollbach J; Kircher S; Wiegering A; Anger F; Rosenwald A; Germer CT; Löb S Int J Colorectal Dis; 2020 Feb; 35(2):365-370. PubMed ID: 31828368 [TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology. Zeng L; Li SH; Xu SY; Chen K; Qin LJ; Liu XY; Wang F; Fu S; Deng L; Wang FH; Miao L; Li L; Liu N; Wang R; Wang HY Front Immunol; 2022; 13():878457. PubMed ID: 35619699 [TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy. Chen TW; Huang KC; Chiang SF; Chen WT; Ke TW; Chao KSC J Cancer Res Clin Oncol; 2019 Apr; 145(4):1043-1053. PubMed ID: 30874889 [TBL] [Abstract][Full Text] [Related]
12. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor. Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257 [TBL] [Abstract][Full Text] [Related]
13. Effector memory cytotoxic CD3 Sun X; Zhai J; Sun B; Parra ER; Jiang M; Ma W; Wang J; Kang AM; Kannan K; Pandurengan R; Zhang S; Solis LM; Haymaker CL; Raso MG; Mendoza Perez J; Sahin AA; Wistuba II; Yam C; Litton JK; Yang F Mod Pathol; 2022 May; 35(5):601-608. PubMed ID: 34839351 [TBL] [Abstract][Full Text] [Related]
14. 53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Huang A; Xiao Y; Peng C; Liu T; Lin Z; Yang Q; Zhang T; Liu J; Ma H Strahlenther Onkol; 2020 May; 196(5):465-473. PubMed ID: 31828392 [TBL] [Abstract][Full Text] [Related]
15. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive values of the immunoscore in patients with rectal cancer. Anitei MG; Zeitoun G; Mlecnik B; Marliot F; Haicheur N; Todosi AM; Kirilovsky A; Lagorce C; Bindea G; Ferariu D; Danciu M; Bruneval P; Scripcariu V; Chevallier JM; Zinzindohoué F; Berger A; Galon J; Pagès F Clin Cancer Res; 2014 Apr; 20(7):1891-9. PubMed ID: 24691640 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival. Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789 [TBL] [Abstract][Full Text] [Related]
19. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study. Nagtegaal ID; Marijnen CA; Kranenbarg EK; Mulder-Stapel A; Hermans J; van de Velde CJ; van Krieken JH BMC Cancer; 2001; 1():7. PubMed ID: 11481031 [TBL] [Abstract][Full Text] [Related]